查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1917792

细胞分离市场－2026-2031年预测

Cell Separation Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计细胞分离市场将从 2025 年的 70.71 亿美元成长到 2031 年的 117.65 亿美元，复合年增长率为 8.86%。

细胞分离市场可望持续成长，这主要得益于其在现代生物医学研发中的基础性作用。该领域专注于从异质混合物中分离特定细胞类型，对多个高影响力领域的发展至关重要。日益严峻的全球健康挑战、生物製造的扩张以及大量的技术和资金投入，共同推动了该市场强劲的商业性成长。

市场扩张的关键驱动因素是全球慢性疾病负担的日益加重，尤其是癌症。细胞分离技术对于更好地了解疾病机制、识别关键生物标记以及开发标靶诊断和治疗方法至关重要。分离和分析稀有细胞群（例如循环性肿瘤细胞(CTC)）是一项变革性应用，能够以微创方式监测疾病进展和治疗效果。这种直接针对常见癌症和其他慢性疾病的应用，确保了对先进分离解决方案的持续需求。

同时，生物製药产业的蓬勃发展也是关键的成长动力。随着对单株抗体、重组蛋白和细胞疗法等复杂生物製药的关注度不断提高，可靠且扩充性的细胞分离已成为至关重要的上游工程。这些先进治疗方法的生产和纯化依赖于精准的细胞分离技术。持续的大规模生物製药研发投入与细胞分离平台的日益普及直接相关，并将这些技术整合到药物研发和生产的核心基础设施中。

干细胞研究和再生医学的快速发展是推动这一趋势的另一个重要因素。干细胞在组织修復、疾病建模和药物筛检方面具有巨大的潜力，但要充分发挥这一潜力，需要高效的技术来分离、纯化和鑑定特定的干细胞群。在这一领域，科学界和临床界的关注度日益提高，加之各方的不懈努力和积极倡导，持续推动着对专用分离试剂、试剂盒和设备的需求，这些试剂、试剂盒和设备旨在处理这些脆弱而珍贵的细胞。

市场发展正受到战略投资倡议和政府大力支持的积极推动。生态系统内的企业已获得大量资金，用于推动平台技术、扩大商业化进程并强化产品系列。这种私营部门的发展势头与旨在促进生物技术和先进製造领域创新的公共津贴和政策倡议相辅相成。此类财政和监管支持将加速新型细胞分离方法从实验室转化为更广泛的商业性和临床应用。

儘管前景乐观，但市场仍面临技术和营运方面的限制。分离纯度和特异性方面仍有挑战，某些调查方法有共分离非目标细胞的风险。此外，先进技术通常需要专门的操作知识和精密仪器，这可能会限制其在资源匮乏环境中的普及和广泛应用。高通量应用的可扩展性也是高效处理大量样本的持续性技术挑战。透过持续创新克服这些限制因素，将是开启下一阶段市场渗透的关键。

从地理角度来看，北美有望继续保持主导得益于其完善的製药和生物技术产业基础、高度集中的研究机构以及对尖端生命科学技术的早期应用。该地区慢性病的高发生率进一步凸显了对先进细胞分离产品的临床和商业性需求。旨在加强生物技术和生物製造能力的国家战略倡议有望进一步巩固这一区域优势。

在竞争格局中，成熟的全球性公司提供全面的产品系列。它们凭藉自身专业知识，提供从以微珠为基础、自动化细胞分选仪到用于科学研究和临床的专用试剂盒等一系列整合解决方案。持续专注于创新、策略合作以及拓展应用支援，对于在这个不断变化的市场中获取价值至关重要。

总而言之，细胞分离市场受到医疗保健、工业和研究领域强大且相互关联的驱动因素的支持。其成长并非仅仅源于样本量的增加，而是与推动下一代医学突破的根本需求密切相关。行业相关人员的成功将取决于克服技术挑战、提高产品的可及性和易用性，以及使产品开发适应治疗方法发现、生物製造和临床诊断不断变化的需求。

本报告的主要优势：

  • 深入分析：获得主要和新兴地区的深入市场洞察，重点关注客户群、政府政策和社会经济因素、消费者偏好、行业垂直领域和其他细分市场。
  • 竞争格局：了解全球主要参与者的策略倡议，并了解透过正确的策略实现市场渗透的潜力。
  • 市场驱动因素与未来趋势：探索推动市场的动态因素和关键趋势，以及它们将如何塑造未来的市场发展。
  • 可操作的建议：利用这些见解，在快速变化的环境中做出策略决策，并发现新的商机和收入来源。
  • 受众广泛：适用于Start-Ups、研究机构、顾问公司、中小企业和大型企业，且经济实惠。

以下是一些公司如何使用这份报告的范例

产业与市场分析、机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法规结构及影响、新产品开发、竞争情报

研究范围：

  • 2021年至2025年的历史数据和2026年至2031年的预测数据
  • 成长机会、挑战、供应链前景、法规结构与趋势分析
  • 竞争定位、策略和市场占有率分析
  • 按业务板块和地区（包括国家）分類的收入和预测评估
  • 公司概况（策略、产品、财务资讯、关键发展等）

目录

第一章执行摘要

第二章 市场概览

  • 市场概览
  • 市场定义
  • 调查范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策与法规
  • 策略建议

第四章 技术展望

第五章 依产品类型分類的细胞分离市场

  • 介绍
  • 消耗品
  • 装置

第六章 细胞分离市场：依方法划分

  • 介绍
  • 离心
  • 滤
  • 萤光活化细胞分选（FACS）
  • 磁激活细胞分选（MACS）
  • 其他的

第七章 细胞分离市场：依应用领域划分

  • 介绍
  • 生物分子分离
  • 癌症研究
  • 干细胞研究
  • 组织再生
  • 体外诊断
  • 其他的

第八章 依最终用户分類的细胞分离市场

  • 介绍
  • 製药和生物技术公司
  • 研究和学术机构
  • 其他的

第九章 细胞分离市场：依地区划分

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 其他的

第十章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 合併、收购、协议和合作
  • 竞争对手仪錶板

第十一章 公司简介

  • Thermo Fisher Scientific, Inc.
  • BD Biosciences（Becton Dickinson Company）
  • Danaher Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Corning Inc.
  • Akadeum Life Sciences
  • QIAGEN NV
  • Miltenyi Biotec GmbH

第十二章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 调查方法
  • 简称
简介目录
Product Code: KSI061615766

Cell Separation Market, with a 8.86% CAGR, is anticipated to reach USD 11.765 billion in 2031 from USD 7.071 billion in 2025.

The cell separation market is positioned for sustained growth, driven by its foundational role in advancing modern biomedical research and therapeutic development. This sector, dedicated to isolating specific cell types from heterogeneous mixtures, is integral to progress across multiple high-impact fields. The convergence of rising global health challenges, expansion in biomanufacturing, and significant technological and financial investments underpins a robust commercial trajectory.

A primary catalyst for market expansion is the escalating global burden of chronic diseases, particularly cancer. Cell separation technologies are indispensable for deepening the understanding of disease mechanisms, identifying critical biomarkers, and developing targeted diagnostics and therapies. The isolation and analysis of rare cell populations, such as circulating tumor cells (CTCs), exemplify a transformative application, enabling minimally invasive monitoring of disease progression and treatment efficacy. This direct link to addressing prevalent oncological and other chronic conditions ensures persistent demand for sophisticated separation solutions.

Concurrently, the robust expansion of the biopharmaceutical industry represents a major growth pillar. As the sector intensifies its focus on complex biologics-including monoclonal antibodies, recombinant proteins, and cell-based therapies-reliable and scalable cell separation becomes a critical upstream process. The production and purification of these advanced therapeutic modalities are contingent on precise cell isolation techniques. Substantial and ongoing investments in biopharmaceutical research and development directly correlate with increased adoption of cell separation platforms, embedding these technologies within the core infrastructure of drug development and manufacturing.

Further momentum is generated by the accelerating frontier of stem cell research and regenerative medicine. The potential of stem cells in tissue repair, disease modeling, and drug screening is vast, yet realizing this potential hinges on the ability to efficiently isolate, purify, and characterize specific stem cell populations. Rising scientific and clinical focus on this field, supported by dedicated initiatives and advocacy, continues to boost demand for specialized separation reagents, kits, and instruments designed to handle these sensitive and valuable cells.

Market advancement is actively propelled by strategic investment initiatives and substantive government support. Companies within the ecosystem are securing significant funding to advance platform technologies, scale commercialization efforts, and enhance product portfolios. This private sector momentum is complemented by public grants and policy initiatives aimed at fostering innovation in biotechnology and advanced manufacturing. Such financial and regulatory support accelerates the translation of novel cell isolation methodologies from research laboratories to broader commercial and clinical applications.

Despite a positive outlook, the market faces certain technical and operational restraints. Challenges pertaining to the purity and specificity of separation remain, with risks of non-target cell co-isolation in certain methodologies. Furthermore, advanced techniques often require specialized operational expertise and sophisticated instrumentation, which can limit accessibility and adoption in resource-constrained settings. Scalability for high-throughput applications also presents an ongoing engineering hurdle for processing large sample volumes efficiently. Addressing these limitations through continuous innovation is key to unlocking the next phase of market penetration.

From a geographical perspective, North America is anticipated to maintain a leadership position. This is attributed to its well-established pharmaceutical and biotechnology ecosystem, a high concentration of research institutions, and the early adoption of cutting-edge life science technologies. A significant prevalence of chronic diseases in the region further underscores the clinical and commercial need for advanced cell separation products. Strategic national initiatives aimed at reinforcing biotechnology and biomanufacturing capabilities are expected to further solidify this regional dominance.

The competitive landscape features established global players offering comprehensive portfolios. Companies leverage their expertise to provide integrated solutions, from magnetic bead-based reagents and automated cell sorters to specialized kits for research and clinical applications. Their continued focus on innovation, strategic collaborations, and expanding application support will be crucial in capturing value in this evolving market.

In summary, the cell separation market is underpinned by strong, interlinked drivers from healthcare, industry, and research. Its growth is not merely a function of increasing sample volumes but is fundamentally tied to enabling next-generation medical breakthroughs. Success for industry participants will depend on navigating technical challenges, enhancing accessibility and ease-of-use, and aligning product development with the evolving needs of therapeutic discovery, bioproduction, and clinical diagnostics.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Cell Separation Market Segmentation

  • By Product Type
  • Consumables
  • Instrument
  • By Method
  • Centrifugation
  • Filtration
  • Fluorescence-activated Cell Sorting (FACS)
  • Magnetic-Activated Cell Sorting (MACS)
  • Others
  • By Application
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration
  • In Vitro-Diagnostics
  • Others
  • By End-User
  • Pharmaceuticals & Bio-Tech Companies
  • Research & Academic Institute
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CELL SEPARATION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Consumables
  • 5.3. Instrument

6. CELL SEPARATION MARKET BY METHOD

  • 6.1. Introduction
  • 6.2. Centrifugation
  • 6.3. Filtration
  • 6.4. Fluorescence-activated cell sorting (FACS)
  • 6.5. Magnetic-Activated Cell Sorting (MACS)
  • 6.6. Others

7. CELL SEPARATION MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Biomolecule Isolation
  • 7.3. Cancer Research
  • 7.4. Stem Cell Research
  • 7.5. Tisue Regeneration
  • 7.6. In Vitro-Diagnostics
  • 7.7. Others

8. CELL SEPARATION MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceuticals & Bio-Tech Companies
  • 8.3. Research & Academic Institute
  • 8.4. Others

9. CELL SEPARATION MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific, Inc.
  • 11.2. BD Biosciences (Becton Dickinson Company)
  • 11.3. Danaher Corporation
  • 11.4. Terumo Corporation
  • 11.5. STEMCELL Technologies Inc.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. Merck KGaA
  • 11.8. Corning Inc.
  • 11.9. Akadeum Life Sciences
  • 11.10. QIAGEN N.V.
  • 11.11. Miltenyi Biotec GmbH

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations